BC
PHIO icon

Broadfin Capital’s Phio Pharmaceuticals PHIO Stock Holding History

Broadfin Capital’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-5
Closed -$585K – 67
2016
Q3 		$585K Sell
5
-3
-38% -$405K 0.06% 69
2016
Q2 		$1.17M Hold
8
– – 0.13% 67
2016
Q1 		$1.35M Sell
8
-1
-11% -$176K 0.16% 66
2015
Q4 		$1.96M Sell
9
-1
-10% -$251K 0.14% 83
2015
Q3 		$2.27M Hold
10
– – 0.18% 79
2015
Q2 		$3M Buy
10
+8
+400% +$2.69M 0.2% 85
2015
Q1 		$811K Hold
2
– – 0.06% 81
2014
Q4 		$1.8M Hold
2
– – 0.16% 72
2014
Q3 		$2.25M Hold
2
– – 0.24% 67
2014
Q2 		$3.4M Hold
2
– – 0.33% 59
2014
Q1 		$4.81M Buy
+2
New +$6.35M 0.47% 51

Other funds holding PHIO

SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $2.24B AUM 17.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return